scholarly article | Q13442814 |
P50 | author | Maxime Cournot | Q51119123 |
P2093 | author name string | Dominique Lauque | |
Meyer Elbaz | |||
Françoise Maupas-Schwalm | |||
Sandrine Charpentier | |||
Jean Marie Botella | |||
P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study | Q24793144 | ||
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
Biomarkers in acute myocardial infarction. | Q33596823 | ||
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 | ||
Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 | ||
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin–neurophysin II precursor | Q34055188 | ||
Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 | ||
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g | Q34154695 | ||
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration | Q34167832 | ||
A simulation study of the number of events per variable in logistic regression analysis | Q34411363 | ||
Missed diagnoses of acute cardiac ischemia in the emergency department. | Q34508319 | ||
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker | Q35754449 | ||
Relationship between a clear-cut alternative noncardiac diagnosis and 30-day outcome in emergency department patients with chest pain | Q36715042 | ||
New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department | Q37009466 | ||
2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice | Q37013737 | ||
Emergent diagnosis of acute coronary syndromes: today's challenges and tomorrow's possibilities | Q37134848 | ||
The effect of emergency department crowding on clinically oriented outcomes | Q37324795 | ||
Copeptin: a biomarker of cardiovascular and renal function | Q37775088 | ||
Clinical value of diagnostic instruments for ruling out acute coronary syndrome in patients with chest pain: a systematic review | Q37777552 | ||
Do risk factors for chronic coronary heart disease help diagnose acute myocardial infarction in the Emergency Department? | Q40061108 | ||
Neuroendocrine activation after acute myocardial infarction | Q41881045 | ||
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis | Q46329565 | ||
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
Hypothalamo-pituitary-adrenal axis response to coronary artery embolization: an ovine model of acute myocardial infarction | Q48788298 | ||
The Association Between Emergency Department Crowding and Adverse Cardiovascular Outcomes in Patients with Chest Pain | Q57750508 | ||
Recommendations for the use of cardiac troponin measurement in acute cardiac care | Q58314269 | ||
P433 | issue | 5 | |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 517-524 | |
P577 | publication date | 2012-05-01 | |
P1433 | published in | Academic Emergency Medicine | Q15755260 |
P1476 | title | Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department | |
P478 | volume | 19 |
Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
Q49170031 | Building a better mousetrap for chest pain |
Q64986825 | Clinical role of serum Copeptin in acute coronary syndrome. |
Q91601225 | Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction |
Q38213084 | Copeptin-marker of acute myocardial infarction |
Q57101391 | Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis |
Q37684756 | Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation |
Q44497204 | Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers |
Q35392693 | Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery |
Q36972479 | The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study |
Q39442697 | Use of copeptin in emergency patients with cardiac chief complaints |
Search more.